KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biolife Solutions (BLFS) Finished Goods (2017 - 2023)

Historic Finished Goods for Biolife Solutions (BLFS) over the last 8 years, with Q1 2023 value amounting to $10.7 million.

  • Biolife Solutions' Finished Goods rose 2513.73% to $10.7 million in Q1 2023 from the same period last year, while for Mar 2023 it was $10.7 million, marking a year-over-year increase of 2513.73%. This contributed to the annual value of $8.3 million for FY2022, which is 3613.03% up from last year.
  • Biolife Solutions' Finished Goods amounted to $10.7 million in Q1 2023, which was up 2513.73% from $8.3 million recorded in Q4 2022.
  • Biolife Solutions' Finished Goods' 5-year high stood at $10.7 million during Q1 2023, with a 5-year trough of $3.0 million in Q2 2019.
  • For the 5-year period, Biolife Solutions' Finished Goods averaged around $7.3 million, with its median value being $7.1 million (2020).
  • In the last 5 years, Biolife Solutions' Finished Goods soared by 33425.93% in 2019 and then plummeted by 983.53% in 2021.
  • Biolife Solutions' Finished Goods (Quarter) stood at $6.1 million in 2019, then increased by 10.56% to $6.7 million in 2020, then fell by 9.84% to $6.1 million in 2021, then skyrocketed by 36.13% to $8.3 million in 2022, then grew by 29.48% to $10.7 million in 2023.
  • Its last three reported values are $10.7 million in Q1 2023, $8.3 million for Q4 2022, and $10.1 million during Q3 2022.